In terms of how it comparises to Ozempic, the researchers wrote in the paper: "Ecnoglutide, a novel GLP-1 receptor agonist, is composed entirely of natural amino acids with chemical modifications to enhance stability and activity, differing from semaglutide by four amino acids." They explained these modifications not only improve how the drug works but the manufacturing process in this case too
L-Carnitine L-Tartrate (LCLT): Often used in sports supplements for potentially better absorption and exercise-related benefits
First-time prescribing of anti-obesity GLP-1s increased 21.7% over the past quarter, with first-time anti-obesity semaglutide use rising by more than 50%, likely influenced by the approval of the oral formulation of Wegovy in late 2025
Diabetes Ther 14:21592172 Aroda VR, Faurby M, Lophaven S, Noone J, Wolden ML, Lingvay I (2021) Insights into the early use of oral semaglutide in routine clinical practice: the IGNITE study
PubMed CrossRef Thomsen M, Holst JJ, Molander A, et al